SCHEMBL3664834

SCHEMBL3664834

CCCCCCCCN1C(=O)CC(CCCCCCCC)(S(=O)(=O)O)C1=O

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 4/20 0.38
PTGS1 P23219 3/20 0.38
PTGS2 P35354 3/20 0.38
FAAH O00519 3/20 0.38
CYP19A1 P11511 12/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8414230 1.00 MGLL (0.38) MGLLPTGS1PTGS2FAAHCYP19A1
SCHEMBL30659956 0.83 PTPN1 (0.32)
SCHEMBL1164102 0.74 MGLL (0.42) MGLLPTGS1PTGS2FAAHCYP19A1
SCHEMBL1472916 0.71 PTGS1 (0.42) MGLLPTGS1PTGS2FAAHCYP19A1
SCHEMBL11435977 0.71 CYP19A1 (0.45) CYP19A1
SCHEMBL9249655 0.69 PTPN1 (0.32)
SCHEMBL5970112 0.69 PTGS1 (0.40) MGLLPTGS1PTGS2FAAHCYP19A1
SCHEMBL6848204 0.67 MGLL (0.38) MGLLPTGS1PTGS2FAAHCYP19A1
SCHEMBL5970157 0.67 PTGS1 (0.38) MGLLPTGS1PTGS2FAAHCYP19A1
SCHEMBL11087474 0.66 SIRT2 (0.36) MGLLPTGS1PTGS2FAAHCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9433615-B2 Animal parasite-control method using insect growth regulators THE HARTZ MOUNTAIN CORPORATION (US) 2016-09-06 US disclosed
EP-2187740-B1 ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS HARTZ MOUNTAIN CORP (US) 2015-11-04 EP disclosed
US-8846722-B2 Animal parasite-control method using insect growth regulators THE HARTZ MOUNTAIN CORPORATION (US) 2014-09-30 US disclosed
US-20140194475-A1 ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS THE HARTZ MOUNTAIN CORPORATION (US) 2014-07-10 US disclosed
US-8563210-B2 Liquid electrophotographic ink concentrates and methods for preparing the same HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2013-10-22 US disclosed
US-20130230340-A1 LIQUID ELECTROPHOTOGRAPHIC INK CONCENTRATES AND METHODS FOR PREPARING THE SAME HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2013-09-05 US disclosed
US-8426100-B2 Liquid electrophotographic ink concentrates and methods for preparing the same HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2013-04-23 US disclosed
US-20120264788-A1 ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS THE HARTZ MOUNTAIN CORPORATION (US) 2012-10-18 US disclosed
US-20120196222-A1 LIQUID ELECTROPHOTOGRAPHIC INK CONCENTRATES AND METHODS FOR PREPARING THE SAME HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2012-08-02 US disclosed
EP-2187740-A1 ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS The Hartz Mountain Corporation (US) 2010-05-26 EP disclosed
WO-2009033175-A1 ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS THE HARTZ MOUNTAIN CORPORATION (US) 2009-03-12 WO disclosed
US-20090069387-A1 ANIMAL PARASITE-CONTROL METHOD USING INSECT GROWTH REGULATORS THE HARTZ MOUNTAIN CORPORATION 2009-03-12 US disclosed
US-7368435-B2 Topical endoparasiticide and ectoparasiticide formulations SUMMIT VETPHARM, LLC (US) 2008-05-06 US disclosed
EP-1796463-A2 TOPICAL ENDOPARASITICIDE AND ECTOPARASITICIDE FORMULATIONS Summit Vetpharm, LLC (US) 2007-06-20 EP disclosed
WO-2006039079-A2 TOPICAL ENDOPARASITICIDE AND ECTOPARASITICIDE FORMULATIONS SUMMIT VETPHARM, LLC (US) 2006-04-13 WO disclosed
US-20060062817-A1 Topical endoparasiticide and ectoparasiticide formulations CEVA ANIMAL HEALTH LLC 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060062817-A1 Topical endoparasiticide and ectoparasiticide formulations NAPRT, NAMPT, PLPBP MGLL 101/4885PTGS1 908/4885PTGS2 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.